Class I
Terminated
0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-02
- Company
- Hospira Inc.
- Recall Initiated
- July 12, 2013
- Posted
- December 25, 2013
- Recall Number
- D-381-2014
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 119,600 vials
- Firm Location
- Lake Forest, IL, United States
Reason for Recall
Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.
Distribution
Nationwide
Lot / Code Info
Lot # 23-338-DK, Exp. 11/14
More recalls by Hospira Inc.
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per car...
May 31, 2017 · Class I
Minibore Extension Set, 59 Inch with Spin Lock Collar, Non-DEHP, Latex-Free
Intended use: For the ad...
Jan 11, 2017
5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, Fo...
Dec 14, 2016 · Class III
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025